![]() |
|
复旦大学附属肿瘤医院肿瘤研究所,乳腺癌研究所,副研究员。2003年毕业于复旦大学上海医学院临床医学专业,获得医学学士学位,2018年获复旦大学上海医学院肿瘤学博士学位。2012-2014年以访问学者身份在美国田纳西大学癌症研究中心进修学习。主持多项国家自然科学基金青年项目和面上项目,参与国家重点基础研究发展计划、上海市科委基础研究项目等,担任国家自然科学基金委评议人。研究成果发表于Oncogene, Theranostics,Journal of Translational Medicine等国际核心杂志。
研究领域:
乳腺肿瘤耐药及复发转移的分子机制和转化性研究 1.HER2阳性乳腺癌治疗敏感性的多组学研究; 2.乳腺癌侵袭转移相关分子标志物的筛选及机制研究; 3.乳腺癌疗效及预后预测相关的分子模型建立及研究。
代表性论著: 1. Xue J#; Chi Y#; Chen Y; Huang S; Ye X; Niu J; Wang W; Pfeffer L M; Shao Z M; Wu Z H*; Wu J*. MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity. Oncogene. 2016 Jan 28; 35(4):448-58. 2. Chi, Yayun#; Xue, Jingyan#; Huang, Sheng#; Xiu, Bingqiu#; Su, Yonghui; Wang, Wei; Guo, Rong; Wang, Lei; Li, Lun; Shao, Zhiming; Jin, Wei; Wu, Zhaohui* ; Wu, Jiong*. CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50. Theranostics. 2019 Sep 21; 9(23):6840-6855. 3. Rong Guo#; Yonghui Su#; Qi Zhang#; Bingqiu Xiu; Sheng Huang; Weiru Chi; Liyi Zhang; Lun Li; Jianjing Hou; Jia Wang; Jiajian Chen; Yayun Chi*; Jingyan Xue*; Jiong Wu*. LINC00478-derived novel cytoplasmic lncRNA LacRNA stabilizes PHB2 and suppresses breast cancer metastasis via repressing MYC targets. Journal of Translational Medicine. 2023 Feb 13; 21(1):120. 4. Jingyan Xue#; Sheng Huang#; Jiaying Chen#; Yi-zuo Chen; Zhi-min Shao; Jiong Wu*; Yayun Chi*. Overexpression of Long Non-Coding RNA Linc01315 Predicts Poor Prognosis in Breast Cancer. Frontiers in Oncology. 2021 Oct 5; 11:562378. 5. Pei Li#; Lun Li#; Bingqiu Xiu; Liyi Zhang; Benlong Yang; Yayun Chi; Jingyan Xue*; Jiong Wu*. The Prognoses of Young Women With Breast Cancer (≤35 years) With Different Surgical Options: A Propensity Score Matching Retrospective Cohort Study. Frontiers in Oncology. 2022 Feb 28; 12:795023.
|
复旦大学肿瘤研究所 通讯地址: 东安路270号2号楼1312室 64175590-5312 Email:fuci2012@126.com Copyright 2013 shca.org.cn All rights reserved. 复旦大学肿瘤研究所 版权所有 |